Genotype^{a} | Hermaphrodite viability (%)^{b} | n^{c} |
---|---|---|

ceh-39(y414) | 101 | 1008 |

xol-1(y9)^{d} | 97 | 1251 |

ceh-39(y414) xol-1(y9)^{d} | 93 | 1120 |

dpy-27(y57) | 77 | 1164 |

dpy-27(y57); xol-1(y9) | 77 | 1435 |

dpy-27(y57); ceh-39(y414) | 18 | 1130 |

dpy-27(y57); xol-1(y9) ceh-39(y414)^{d} | 70 | 964 |

sdc-2(RNAi) | 84 | 1512 |

xol-1(y9) sdc-2(RNAi)^{d} | 84 | 722 |

ceh-39(y414) sdc-2(RNAi) | 53 | 1157 |

ceh-39(y414) xol-1(y9) sdc-2(RNAi)^{d} | 89 | 1416 |

↵

*a*RNAi was applied as explained in Table 1, footnote*a*.↵

*b*Hermaphrodite viability was calculated by the following formula: (no. of adult hermaphrodites)/(total no. of embryos) × 100.↵

*c**n*is the total number of embryos from six independent sets of progeny counts.↵

*d*Strain also includes the marker*dpy-6(e14)*.